Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

Bayer raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a ...

Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

German pharmaceutical and agrochemical company Bayer saw profits fall again in 2024 and faces another difficult year ahead, ...

With a career spanning more than four decades, starting in 1983 at PwC, Stephen has worked across global Pharma and Med Devices at GSK, Schering-Plough Pharmaceuticals ... Thomas Udesen leads global ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

PALM BEACH, FL—President Donald Trump announced on Tuesday his plan to impose auto tariffs "in the neighborhood of 25%" while also considering similar or higher duties on semiconductor and ...

During the cabinet discussion held yesterday (Monday), Attorney General Gali Baharav-Miara demanded that the ministers consult with her regarding the legality of US President Donald Trump's plan ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...